Last reviewed · How we verify
candesartan cilexetil 32mg, amlodipine 10mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
candesartan cilexetil 32mg, amlodipine 10mg (candesartan cilexetil 32mg, amlodipine 10mg) — HK inno.N Corporation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| candesartan cilexetil 32mg, amlodipine 10mg TARGET | candesartan cilexetil 32mg, amlodipine 10mg | HK inno.N Corporation | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- candesartan cilexetil 32mg, amlodipine 10mg CI watch — RSS
- candesartan cilexetil 32mg, amlodipine 10mg CI watch — Atom
- candesartan cilexetil 32mg, amlodipine 10mg CI watch — JSON
- candesartan cilexetil 32mg, amlodipine 10mg alone — RSS
Cite this brief
Drug Landscape (2026). candesartan cilexetil 32mg, amlodipine 10mg — Competitive Intelligence Brief. https://druglandscape.com/ci/candesartan-cilexetil-32mg-amlodipine-10mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab